3 unchanged sentences
Amended and Restated Bylaws of the Registrant (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on October 13, 2015).
−Removed: Third Amended and Restated Non-Employee Director Compensation Policy (incorporated herein by reference to Exhibit 10.15 to the Registrant’s Annual Report on Form 10-K (File No.
−Removed: 001-37581), filed with the SEC on February 25, 2020).
−Removed: Loan and Security Agreement, by and among the Registrant, Confluence Discovery Technologies, Inc.
−Removed: and Silicon Valley Bank, dated as of March 30, 2020 (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on March 31, 2020).
−Removed: Warrant to Purchase Stock, issued to Silicon Valley Bank, dated as of March 30, 2020 (incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on March 31, 2020).
−Removed: Open Market Sale Agreement, dated March 13, 2020, by and between the Registrant and Jefferies LLC (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on March 13, 2020).
−Removed: Second Amendment to Sublease, dated as of April 29, 2020, by and between the Registrant and Auxilium Pharmaceuticals, LLC.
+Added: 001-37581), filed with the SEC on June 24, 2020).
+Added: Second Amendment to Sublease, dated as of April 29, 2020, by and between the Registrant and Auxilium Pharmaceuticals, LLC (incorporated herein by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37581), filed with the SEC on May 7, 2020).
+Added: First Amendment to Clinical and Commercial Supply Agreement, dated as of June 12, 2020, by and between the Registrant and PeroxyChem LLC.
Certification of Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act.
1 unchanged sentence
Certifications of Principal Executive Officer and Principal Financial Officer under Section 906 of the Sarbanes-Oxley Act.
−Removed: XBRL Instance Document
−Removed: XBRL Taxonomy Extension Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
−Removed: XBRL Taxonomy Extension Label Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
+Added: Inline XBRL Taxonomy Extension Schema Document
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document
+Added: Inline XBRL Taxonomy Extension Definition Linkbase Document
+Added: Inline XBRL Taxonomy Extension Label Linkbase Document
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
Filed herewith.
1 unchanged sentence
Section 1350, and are not being filed for purposes of Section 18 of the Exchange Act and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
−Removed: Indicates management contract or compensatory plan.
+Added: Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the SEC, certain portions of this exhibit have been redacted because such portions, indicated by asterisks, are both not material and would likely cause competitive harm to the Registrant if publicly disclosed.
+Added: The Registrant hereby agrees to furnish supplementally to the SEC, upon its request, an unredacted copy of this exhibit.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ACLARIS THERAPEUTICS, INC.
+Added: August 7, 2020
/s/ Neal Walker
1 unchanged sentence
(On behalf of the Registrant)
+Added: August 7, 2020
/s/ Frank Ruffo
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.